United States · Funded startup
5 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$155Mraised across 5 rounds since 2004, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
Caxton AssociatesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Caxton AssociatesGollust ManagementMountain Trail InvestmentsSunAmericaMissing a round, or an investor who was in one? Tell us.
Synta Pharmaceuticals's investors include Galleon Group, Duquesne Capital Management, Caxton Associates, Gollust Management and Mountain Trail Investments, and 1 more on record.
Synta Pharmaceuticals has raised $155M across 5 rounds since 2004.
Synta Pharmaceuticals's most recent round was an Undisclosed round of $39M in Apr 2015.
Synta Pharmaceuticals's largest round on record is $50M (Series C), in Jan 2004.
Synta Pharmaceuticals's first round on record, in Jan 2004, was backed by Galleon Group, Duquesne Capital Management and Caxton Associates and 3 others.
Synta Pharmaceuticals's latest named round is an Undisclosed round, in Apr 2015.
Synta Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·